1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow lenalidomide standard of care: new trials by email Literature Review of lenalidomide standard of care trials Research Report on lenalidomide standard of care
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma Imetelstat (7.5 mg/kg), lenalidomide standard of care, Imetelstat (9.4 mg/kg) - Multiple Myeloma | Phase 2 | Completed | Geron Corporation | 13 | 2010-11-01 | 2026-06-17 |
Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
United States (1)
Carol Ann Huff, M.D. (1) · Joe Eid (1)